Examining family member characteristics by treatment status of the relative with substance use problems [0.03%]
患病家庭成员的家庭构成特点分析
Raquel Radaeli de Figueiredo van der Molen,Ronaldo Laranjeira,Martha Canfield et al.
Raquel Radaeli de Figueiredo van der Molen et al.
Background and objectives: Family involvement is increasingly recognised as important to the treatment and recovery of individuals with substance use disorders. While affected family members (AFMs) can play a critical rol...
Assessment of primary care team-based learning sessions for opioid use disorder [0.03%]
初级保健团队学习在阿片类药物使用障碍中的应用评估
Cory B Lutgen,Elisabeth Callen,Elise Robertson et al.
Cory B Lutgen et al.
Background and objectives: Often patients with opioid use disorder (OUD) do not receive needed treatment; in part, this is due to the lack of available clinicians who treat OUD. To address the workforce gap, this study as...
Tyler Pia,Andrea H Weinberger
Tyler Pia
Background and objectives: Synthetic cannabinoids (SCs) cause adverse physiological and psychological effects. There is little information about current SC use in the general United States (U.S.) population (i.e., nonclin...
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis-induced psychosis: A longitudinal study [0.03%]
持续使用大麻对大麻诱发的精神病后的抑郁症、精神病和自杀倾向的影响：一项纵向研究
Valerio Ricci,Domenico De Berardis,Giovanni Martinotti et al.
Valerio Ricci et al.
Background and objectives: Cannabis use is associated with psychotic disorder onset and exacerbation. This study examines how continued cannabis use affects depressive symptoms, psychotic symptoms, and suicidal behaviors ...
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate-to-severe alcohol use disorder [0.03%]
退伍军人中启动治疗的新发中重度酒精使用障碍患者的治疗模式和医疗资源利用情况
Regina Grebla,Teresa L Kauf,Angela Lax et al.
Regina Grebla et al.
Background and objectives: Several medications for alcohol use disorder (MAUDs) are recommended to treat alcohol use disorder (AUD) in the Veterans Affairs (VA) guidelines. This study descriptively characterized treatment...
The association between cannabis use and suicidal intensity in psychiatric inpatients [0.03%]
关于精神病住院患者使用大麻与自杀强度之间的关联研究
Adeolu Funso Oladunjoye,Alan Swann,Thomas R Kosten et al.
Adeolu Funso Oladunjoye et al.
Background: Over the past 15 years, most states have legalized the medical use of cannabis. Since then, daily use nearly tripled while the number of adults dying by suicide increased by 31%. Key studies found a greater su...
A review of the complex intersection between religion, spirituality, and harm reduction [0.03%]
宗教、精神信仰与危害减少之间的复杂关系综述
Jessica Van Denend,Jeremy Weleff,Kelly Park et al.
Jessica Van Denend et al.
Background and objectives: Within substance use research, religion and spirituality (r/s) have been understudied in relation to harm reduction approaches. We perform a literature review to characterize various intersectio...
Brief Report: Effectiveness of two financial incentives on patient follow-up after brief substance use disorder inpatient treatment [0.03%]
简报：两种经济激励对物质使用障碍门诊治疗后的患者随访效果的影响
Mia A Haidamus,Leah A Majumder,Adriana Chen et al.
Mia A Haidamus et al.
Background and objectives: Clinical follow-up data after substance use disorder (SUD) treatment provides important information about treatment effectiveness, yet compliance is a challenge. We compared financial incentives...
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy [0.03%]
孕期滥用阿片类药物患者的月予布普品缓释注射剂（商品名：舒洛代）疗法
Melinda Ramage,Becky Bishop,Vikki Mangano et al.
Melinda Ramage et al.
Background and objectives: Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of...
Pain intensity in patients using extended-release naltrexone or opioid agonists and its effect on extended-release naltrexone treatment outcomes [0.03%]
缓释纳曲酮治疗患者的疼痛强度及其对长效纳曲酮治疗结局的影响
Farid Juya,Kristin K Solli,Line Holtan et al.
Farid Juya et al.
Background and objectives: Extended-release naltrexone (XR-NTX) is an opioid antagonist effective for treating opioid use disorder (OUD). However, concerns about inadequate pain management may limit its use. This study wi...